Stock comparison
AMGEN INC is 104.0x more valuable than Taysha Gene Therapies, Inc. by market capitalization ($196.28 B vs $1.89 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 104.0x more valuable than Taysha Gene Therapies, Inc. by market capitalization ($196.28 B vs $1.89 B).
Market value leader
AMGN
AMGEN INC is 104.0x more valuable than Taysha Gene Therapies, Inc. by market capitalization ($196.28 B vs $1.89 B).
Revenue leader
AMGN
TSHA: $9.77M vs AMGN: $36.75B.
Profit leader
AMGN
TSHA: -$109.00M vs AMGN: $7.71B.
Margin leader
AMGN
TSHA: -1115.3% vs AMGN: 21.0% net margin.
| Metric | TSHA | AMGN |
|---|---|---|
| Market cap | $1.89 B | $196.28 B |
| US-listed rank | #2192 | #75 |
| Revenue (latest FY) | $9.77M | $36.75B |
| Net income (latest FY) | -$109.00M | $7.71B |
| Net margin | -1115.3% | 21.0% |
| P/E (trailing FY) | - | 25.5x |
| SEC filings | 384 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 104.0x more valuable than Taysha Gene Therapies, Inc. by market capitalization ($196.28 B vs $1.89 B).
In their latest fiscal years, Taysha Gene Therapies, Inc. reported $9.77M in revenue while AMGEN INC reported $36.75B.
Full pages: Taysha Gene Therapies, Inc. and AMGEN INC, or browse the full rankings.